2C-T-4 intoxication: Acute psychosis caused by a designer drug

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 2, 2008, Pages 243-

  Miyajima, Miho ^a,d   Matsumoto, Toshihiko ^b   Ito, Shigeo ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,5 DIMETHOXY 4 ISOPROPYLSULFANYLPHENYL)ETHANAMINE; DESIGNER DRUG; ETHYLAMINE; UNCLASSIFIED DRUG;

ACUTE PSYCHOSIS; ADULT; CASE REPORT; DELUSION; FEAR; HALLUCINATION; HUMAN; LETTER; MALE; SEXUAL BEHAVIOR;

ADULT; DELUSIONS; DESIGNER DRUGS; HALLUCINOGENS; HUMANS; MALE; PHENETHYLAMINES; PSYCHOSES, SUBSTANCE-INDUCED; SUBSTANCE ABUSE DETECTION;

EID: 42149174368     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01764.x     Document Type: Letter

References (5)

1. Matsumoto T, Okada T. Designer drugs as a cause of homicide. Addiction 2006 101 : 1666 1667.
2. Curtis B, Kemp P, Harty L, Choi C, Christensen D. Postmortem identification and quantitation of 2,5-dimethoxy-4-n-propylthiophenethylamine using GC-MSD and GC-NPD. J. Anal. Toxicol. 2003 27 : 493 498.
3. Drug Enforcement Administration (DEA) Department of Justice. Schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)- propylthiophenethylamine and N-benzylpiperazine into Schedule I of the Controlled Substances Act. Final rule. Fed. Regist. 2004 69 : 12 94 12 97.
4. Shulgin A. PIHKAL: A Chemical Love Story. Transform Press, Berkeley, CA, 1991.
5. Habrdova V, Peters FT, Theobald DS, Maurer HH. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry. J. Mass Spectrom. 2005 40 : 785 795.